The San Diego-based company posted a loss of -$7.4 million, or -9¢ per share, on sales of $171.2 million for the 3 months ended Dec. 31, for bottom-line loss of -593.3% on sales growth of 30.9% compared with the same period last year.
Adjusted to exclude 1-time items, earnings per share were -9¢, a penny ahead of consensus on The Street, where analysts were looking for sales of $167.3 million.
Get the full story at our sister site, Drug Delivery Business News.
The post DexCom beats Street with Q4 earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2mt1eHB
Cap comentari:
Publica un comentari a l'entrada